Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES (GILD)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Sector news Bio Therapeutic Drugs
01/17 CELGENE : Conducts Deal Talks With Juno -- WSJ
01/16 CELGENE : in Talks to Buy Juno Therapeutics -- Update
01/16 CELGENE : in Talks to Buy Juno Therapeutics
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/08 SANOFI : and Regeneron boost investment in cancer drug cemiplimab
01/07 ALNYLAM PHARMACEUTICALS : Sanofi Restructure RNAi Rare-Disease Alliance -- Updat..
01/07 ALNYLAM PHARMACEUTICALS : Sanofi Restructure RNAi Rare-Disease Alliance
01/05 Best week since April for European shares as UK, Swiss indexes hit records
2017 U.S. tax cuts mix pleasure and pain for Europe's dollar earners
2017 STOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
2017 ALNYLAM PHARMACEUTICALS : Stock Rises as FDA Lifts Study Hold
2017 France's Sanofi pins hopes on new drugs after setbacks
2017 Sanofi investors hungry for drug progress and deal news
2017 Tax-loss selling to pressure 2017's losers in December
2017 GENMAB : and J&J 'love' partnership as some ponder takeover
2017 BIOGEN : Alkermes Join Forces for Multiple Sclerosis Drug
2017 Regeneron drops eye-drug combination as Novartis chases Eylea
2017 BAYER : Amikacin Inhale Fails to Meet Objectives in Phase 3 Trial
2017 Exclusive - Prescient messages about Indian companies circulate in WhatsApp g..
2017 Recovery rally for European stocks leaves oil sector behind
2017 Poor earnings updates keep European shares at seven-week low
2017 NOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
2017 Prosecutors search Metro offices in insider trading probe
2017 As Experimental Treatments Grow, Families Face Tough Choices
2017 SANOFI : and Regeneron Report Positive Asthma Trial Results
2017 Regeneron-Sanofi drug succeeds mid-stage study
2017 Appeals Court Rules Against Amgen in Patent Case -- Update
2017 Appeals Court Rules Against Amgen in Patent Case
2017 Lonza CFO sees in-house growth, not takeovers, to grow drug services
2017 SANOFI : Alnylam Report Positive Patisiran Phase III Trial, First-Ever for RNAi ..
2017 Cyclicals boost European shares while Dixons Carphone plummets
2017 Three CEOs resign from Trump council over Charlottesville
2017 Hot Stocks to Watch in the U.S. and Canada
2017 Cyclicals and ex-divs send European shares to four-month low
2017 France's Sanofi raises earnings forecast, pleased with eczema drug uptake
2017 UNITED THERAPEUTICS : in Settlement Talks With Justice Department -- Update
2017 Autos and energy firms boost European shares as earnings roll in, banks held ..
2017 ELI LILLY AND : to Delay Arthritis Drug Application -- Market Talk
2017 Poor test results for Roche cloud growth prospects
2017 FDA panel backs Novartis' pioneering new cancer gene therapy
2017 UK and industrials prominent in Goldman strategists' M&A target reshuffle
2017 Novartis eye drug works with fewer injections than rival
2017 JOHNSON & JOHNSON : flu drug succeeds in mid-stage trial
2017 Sanofi to invest further in biologics
2017 Bluebird Bio stock jumps 7% after Maxim Group upgrades to buy -- MarketWatch
2017 UK competition watchdog accuses Merck of obstructing biosimilars
2017 Sanofi pegs U.S. drug price rises to below healthcare inflation
2017 VERTEX PHARMACEUTICALS INCORPORATED : Trump's Pick to Lead FDA Has Backing of Bi..
2017 REGENERON SHARES POISED FOR REBOUND : Barron's
2017 REGENERON PHARMACEUTICALS : shares poised for rebound - Barron's
Financials ($)
Sales 2017 25 844 M
EBIT 2017 15 686 M
Net income 2017 10 478 M
Debt 2017 13 136 M
Yield 2017 2,61%
P/E ratio 2017 10,51
P/E ratio 2018 14,16
EV / Sales 2017 4,60x
EV / Sales 2018 5,26x
Capitalization 106 B
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
GILEAD SCIENCES14.10%105 754
VERTEX PHARMACEUTICALS4.76%39 951
REGENERON PHARMACEUTICALS-0.50%39 917
GENMAB10.50%11 762
EXELIXIS, INC.-9.57%8 284
BLUEBIRD BIO INC2.25%8 064
JUNO THERAPEUTICS INC51.50%7 742
NEUROCRINE BIOSCIENCES, INC.-2.20%7 140
BIOVERATIV INC15.58%6 937
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.9.39%6 614
BIOCON LTD0.19%5 353
BEIGENE LTD (ADR)5.02%5 123
PEPTIDREAM INC13.49%4 839
SAREPTA THERAPEUTICS INC11.14%4 032
HUALAN BIOLOGICAL ENGINEERING INC--.--%3 988
TESARO INC-23.37%3 476
AVEXIS INC-0.45%3 461
AGIOS PHARMACEUTICALS INC23.02%3 407
BEIJING SL PHARMACEUTICAL CO LTD--.--%3 356
LOXO ONCOLOGY INC7.47%2 899
CLOVIS ONCOLOGY INC-19.22%2 782